Vandazole generic
Vandazole is an anti-infective drug owned by Teva Pharmaceuticals. It contains the active ingredient metronidazole and was first authorised for market use on 20 May, 2005. Vandazole is available in gel;vaginal dosage forms, and it holds a total of 1 patent.
When will Vandazole generic be available?
The generic versions of Vandazole are set to be released post September 22, 2024, once the last patent 'US7456207 titled Vaginal pharmaceutical compositions and methods for preparing them', expires.
Vandazole uses
Vandazole, containing the active ingredient metronidazole, is used for treating certain types of infections, primarily those caused by bacteria in different parts of the body. metronidazole, as the primary ingredient, makes Vandazole effective in treating these infections.
Vandazole patent expiration
Vandazole's generic will hit the market after its only patent 'US7456207 titled Vaginal pharmaceutical compositions and methods for preparing them' expires on September 22, 2024. Below are the details of the patent: